Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases

Antibiotics - Switzerland
doi 10.3390/antibiotics8020072
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Increased Severity of Lyme Disease Illness in Children Due to Concurrent Babesiosis. • 1042

Pediatric Research
Child HealthPediatricsPerinatology
1996English

Castleman's Disease in Childhood: Report of Three Cases and Review of the Literature

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2011English

EEG Biofeedback in the Treatment of Lyme Disease:

Journal of Neurotherapy
1995English

Adult Gaucher Disease in Southern Tunisia: Report of Three Cases

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2012English

The Use of Dapsone as a Novel “Persister” Drug in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome

Journal of Clinical and Experimental Dermatology Research
2016English

Treatment of Immobilisation Hypercalcaemia in Acute Intermittent Porphyria: Experience From Three Cases.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1997English

Selective Inhibition of Angiotensin Pressor Responses in the Pithed Rat by Tetraethylthiuram Disulphide (Disulfiram) and Sodium Diethyldithiocarbamate (DDC)

British Journal of Pharmacology
Pharmacology
1972English

Babesiosis in Long Island: Review of 62 Cases Focusing on Treatment With Azithromycin and Atovaquone

Annals of Clinical Microbiology and Antimicrobials
MedicineInfectious DiseasesMicrobiology
2017English

Dealing With Lyme Disease Treatment

American Journal of Medicine
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy